Home | Welcome to Contract Pharma   
Last Updated Saturday, March 28 2015

Print RSS Feed

SNBL Appoints Safety Assessment Director

Published January 10, 2013
Related Searches: cro industry Toxicology CRO
Steve Glaza has been appointed director of safety assessment at SNBL USA. Mr. Glaza joins the leadership team and is responsible for all facets of the safety assessment department, managing day-to-day operations to ensure continued operational and scientific excellence. In addition, he will work with the executive management team in formulating and directing current and long-range plans, objectives and policies to support sponsors with compliance and efficiency.
Prior to joining the company, Mr. Glaza spent 30 years at Covance Laboratories. He began as a group leader in the toxicology department and moved up the ranks to manager/study director, then associate director of formulations and associate director of toxicology/safety assessment. He became the site manager for the dedicated client facility, taking the position of associate director and site scientific lead of safety assessment.
“We are very excited to have Steve join SNBL USA,” said Dr. Thomas Beck, SNBL USA president and chief operating officer. “His wealth of experience in the CRO industry makes him an ideal team leader to successfully synchronize industry regulations and compliance with client expectations."

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On